Intra-tumoral injection of doxorubicin (Adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects

Hitoshi Idani, Junji Matsuoka, Tatsuji Yasuda, Kazuko Kobayashi, Noriaki Tanaka

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Intra-tumoral injection of doxorubicin (Adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects'. Together they form a unique fingerprint.

Medicine & Life Sciences